PAK5‐stabilized Smuc confers renal cell carcinoma metastasis
Main Authors: | Fu‐Chun Huo, Zhi‐Man Zhu, Qiu‐Ying Du, Dong‐Sheng Pei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.559 |
Similar Items
-
The levels of sMUC-1 in patients with multiple myeloma
by: Janusz Dziecioł, et al.
Published: (2012-01-01) -
Targeting group II PAKs in cancer and metastasis.
by: Eswaran, J, et al.
Published: (2009) -
Targeting group II PAKs in cancer and metastasis.
by: Eswaran, J, et al.
Published: (2009) -
Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2
by: Hao Yang, et al.
Published: (2024-01-01) -
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
by: Tong-tong Li, et al.
Published: (2021-08-01)